tiprankstipranks

Paul Savas Insider Profile

4 Followers
Paul Savas, Director at vTv Therapeutics, holds 307.85K shares in SIGA Technologies (Ticker: SIGA), holds 91.78K shares in vTv Therapeutics (Ticker: VTVT), holds 19.80K shares in Revlon (Ticker: REVRQ).
tipranks
Paul Savas

Paul Savas
vTv Therapeutics (VTVT)
Director

Ranked #62,779 out of 97,944 Corporate Insiders

Profitable Transactions

38%
6 out of 16 Profitable Transactions

Average Return

-4.10%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$4M
58.87%
41.13%
A breakdown of Paul Savas's holdings

Insider Roles

SIGA Technologies
(SIGA)
Director
vTv Therapeutics
(VTVT)
Director
Roles that Paul Savas holds in companies

Most Profitable Insider Trade

Stock:
SIGA Technologies
(SIGA)
Rating:Informative Buy
Date:Dec 10, 2019 - Dec 10, 2020
Return:+61.20%
The most profitable trade made by Paul Savas

Paul Savas's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
vTv Therapeutics
Sep 06, 2018
Director
Informative Buy
5.00K
$1.68M
REVRQ
Revlon
Nov 14, 2016
Informative Buy
232.49K
$1.39K
SIGA Technologies
May 22, 2020
Director
Uninformative Buy
89.85K
$2.40M
List of latest transactions for each holding click on a transaction to see Paul Savas's performance on stock

Paul Savas insider profile FAQ

What is the percentage of profitable transactions made by Paul Savas?
The percentage of profitable transactions made by Paul Savas is 38%.
    What is the average return per transaction made by Paul Savas?
    The average return per transaction made by Paul Savas is -4.10%.
      What stocks does Paul Savas hold?
      Paul Savas holds: VTVT, REVRQ, SIGA stocks.
        What was Paul Savas’s latest transaction?
        Paul Savas latest transaction was an Uninformative Buy of $89.85K.
          What was Paul Savas's most profitable transaction?
          Paul Savas’s most profitable transaction was an Informative Buy of SIGA stock on December 10, 2019. The return on the trade was 61.20%.
            What is Paul Savas's role in vTv Therapeutics?
            Paul Savas's role in vTv Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.